MedTrace Logo

Transcatheter Microguidewire Drilling for Transseptal Left Atrial Access

NCT04561908 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-04-29

No results posted yet for this study

Summary

This study aims to investigate the safety and efficacy of transcatheter microguidewire drilling (TMD) for transseptal left atrial access in patients with abnormal atrial septal morphology.

Conditions

  • Heart Diseases
  • Atrial Septal Dilatation

Interventions

DEVICE

Transseptal puncture with Brockenbrough-needle

Conventional transseptal puncture with Brockenbrough-needle

DEVICE

Microguidewire-assisted transseptal puncture

Microguidewire-assisted transseptal puncture (0.014-inch microguidewire)

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Chaowu Yan, PhD and MD · Chinese Academy of Medical Sciences, Fuwai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-04
Primary Completion
2022-09-04
Completion
2022-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04561908 on ClinicalTrials.gov